Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

1.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429. Epub 2009 Nov 10.

PMID:
19903678
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.

Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.

Leuk Res. 2010 Jun;34(6):723-7. doi: 10.1016/j.leukres.2009.10.028. Epub 2009 Nov 26.

PMID:
19944463
[PubMed - indexed for MEDLINE]
3.

Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.

Malcovati L.

Leuk Res. 2007 Dec;31 Suppl 3:S2-6. Review.

PMID:
18037415
[PubMed - indexed for MEDLINE]
4.

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Malcovati L, Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Blood. 2008 Aug 1;112(3):895-902. doi: 10.1182/blood-2008-03-143735. Epub 2008 May 22.

PMID:
18497321
[PubMed - indexed for MEDLINE]
Free Article
5.

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A; GITMO.

Haematologica. 2008 Oct;93(10):1514-22. doi: 10.3324/haematol.12828. Epub 2008 Aug 25.

PMID:
18728030
[PubMed - indexed for MEDLINE]
Free Article
6.

Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.

Sivgin S, Baldane S, Kaynar L, Kurnaz F, Pala C, Ozturk A, Cetin M, Unal A, Eser B.

Neoplasma. 2012;59(2):183-90.

PMID:
22248276
[PubMed - indexed for MEDLINE]
7.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

PMID:
19135940
[PubMed - indexed for MEDLINE]
8.

Does iron overload really matter in stem cell transplantation?

Armand P, Sainvil MM, Kim HT, Rhodes J, Cutler C, Ho VT, Koreth J, Alyea EP, Neufeld EJ, Kwong RY, Soiffer RJ, Antin JH.

Am J Hematol. 2012 Jun;87(6):569-72. doi: 10.1002/ajh.23188. Epub 2012 Apr 4.

PMID:
22473510
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Meyer SC, O'Meara A, Buser AS, Tichelli A, Passweg JR, Stern M.

Biol Blood Marrow Transplant. 2013 Mar;19(3):440-4. doi: 10.1016/j.bbmt.2012.10.012. Epub 2012 Oct 23.

PMID:
23089566
[PubMed - indexed for MEDLINE]
10.

Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

Kröger N, Zabelina T, van Biezen A, Brand R, Niederwieser D, Martino R, Lim ZY, Onida F, Schmid C, Garderet L, Robin M, van Gelder M, Marks R, Symeonidis A, Kobbe G, de Witte T; MDS Subcommittee of the Chronic Leukemia Working Party (CLWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Haematologica. 2011 Feb;96(2):291-7. doi: 10.3324/haematol.2010.031229. Epub 2010 Oct 22.

PMID:
20971823
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.

Kim YR, Kim JS, Cheong JW, Song JW, Min YH.

Acta Haematol. 2008;120(3):182-9. doi: 10.1159/000187646. Epub 2009 Jan 5.

PMID:
19129689
[PubMed - indexed for MEDLINE]
12.

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH.

Biol Blood Marrow Transplant. 2011 Jun;17(6):852-60. doi: 10.1016/j.bbmt.2010.09.006. Epub 2010 Sep 18.

PMID:
20854920
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.

Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.

Biol Blood Marrow Transplant. 2010 Jan;16(1):115-22. doi: 10.1016/j.bbmt.2009.09.011. Epub 2009 Sep 18.

PMID:
19766730
[PubMed - indexed for MEDLINE]
14.

Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M.

Biol Blood Marrow Transplant. 2009 Feb;15(2):195-204. doi: 10.1016/j.bbmt.2008.11.012.

PMID:
19167679
[PubMed - indexed for MEDLINE]
15.

Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.

Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J, Kalaycio M, Copelan E.

Br J Haematol. 2009 Aug;146(3):310-6. doi: 10.1111/j.1365-2141.2009.07774.x. Epub 2009 Jun 8.

PMID:
19508292
[PubMed - indexed for MEDLINE]
16.

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

Ditschkowski M, Elmaagacli AH, Trenschel R, Gromke T, Steckel NK, Koldehoff M, Beelen DW.

Haematologica. 2012 Oct;97(10):1574-81. doi: 10.3324/haematol.2011.061168. Epub 2012 Apr 4.

PMID:
22491742
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.

Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ.

Bone Marrow Transplant. 2008 Dec;42(12):799-805. doi: 10.1038/bmt.2008.262. Epub 2008 Sep 1.

PMID:
18762767
[PubMed - indexed for MEDLINE]
18.

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.

Wermke M, Schmidt A, Middeke JM, Sockel K, von Bonin M, Schönefeldt C, Mair S, Plodeck V, Laniado M, Weiss G, Schetelig J, Ehninger G, Theurl I, Bornhäuser M, Platzbecker U.

Clin Cancer Res. 2012 Dec 1;18(23):6460-8. doi: 10.1158/1078-0432.CCR-12-1683. Epub 2012 Sep 18.

PMID:
22991415
[PubMed - indexed for MEDLINE]
Free Article
19.

Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).

Platzbecker U, Bornhäuser M, Germing U, Stumpf J, Scott BL, Kröger N, Schwerdtfeger R, Böhm A, Kobbe G, Theuser C, Rabitsch W, Valent P, Sorror ML, Ehninger G, Deeg HJ.

Biol Blood Marrow Transplant. 2008 Nov;14(11):1217-25. doi: 10.1016/j.bbmt.2008.08.006.

PMID:
18940675
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH.

Blood. 2007 May 15;109(10):4586-8. Epub 2007 Jan 18.

PMID:
17234738
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk